Lishi Lin
5PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 20, 2024
Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors.Lishi Lin, Aletta P I Houwink, Jolanda M van Dieren
|Mar 01, 2024
Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data.Cedric Lau, Ma Ida Mohmaed Ali, Lishi Lin
|Jun 22, 2023
Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients.Lishi Lin, Hannerieke J Barkman, Egbert F Smit
|Jul 01, 2022
Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR-mutant non-small cell lung cancer.Julie M Janssen, Remy B Verheijen, Tirsa T van Duijl
|Dec 11, 2021
Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice.Lishi Lin, Egbert F Smit, Adrianus J de Langen
Pageof 1
